Influenza is a viral infection of the respiratory system that causes fever, muscle aches, runny nose, cough, congestion, headaches, and fatigue in infected people. Types A, B, C, and D are the four types of influenza viruses. Human influenza viruses, such as type A and B influenza viruses, are primarily responsible for seasonal flu epidemics each year. The two subtypes of Type A viruses are named upon differences in two viral surface proteins called hemagglutinin (H) and neuraminidase (N). Infections of influenza type C cause a mild respiratory illness and do not spread epidemics, whereas influenza D viruses mostly affect cattle and do not cause illness in humans.
The "Global Influenza Vaccines Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the influenza vaccines market with detailed market segmentation by vaccine type, virus type and age group. The report provides key statistics on the market status of the leading influenza vaccines market players and offers key trends and opportunities in the market.
- Based on vaccine type the market is segmented as, quadrivalent vaccines, trivalent vaccines.
- Based on virus type the market is segmented as, influenza virus type A, influenza virus type B.
- Based on age group the market is segmented as, pediatrics, adult.
- Rising in government initiatives to ensure well-being and good health of population.
- Less side effects associated with influenza vaccines, advancements in existing vaccines, and development of novel vaccines.
- Moreover, funding and investments by companies in R&D activities supplement the growth of the Influenza vaccine market.
- However, stringent approval procedures for vaccines, long time period required for vaccine development are expected to restrain market growth during the forecast period.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The influenza vaccines market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the influenza vaccines market in these regions.
IMPACT OF COVID-19 ON INFLUENZA VACCINES MARKET
COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.
The report covers key developments in the influenza vaccines market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from influenza vaccines market are anticipated to lucrative growth opportunities in the future with the rising demand for influenza vaccines in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the influenza vaccines market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
Serum Institute of India Pvt. Ltd
Mitsubishi Tanabe Pharma Corporation
Merck Sharp and Dohme Corp
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.